252 related articles for article (PubMed ID: 26491294)
1. Anti-transferrin receptor-modified amphotericin B-loaded PLA-PEG nanoparticles cure Candidal meningitis and reduce drug toxicity.
Tang X; Liang Y; Zhu Y; Xie C; Yao A; Chen L; Jiang Q; Liu T; Wang X; Qian Y; Wei J; Ni W; Dai J; Jiang Z; Hou W
Int J Nanomedicine; 2015; 10():6227-41. PubMed ID: 26491294
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral
Zhou L; Zhang P; Chen Z; Cai S; Jing T; Fan H; Mo F; Zhang J; Lin R
Int J Nanomedicine; 2017; 12():4269-4283. PubMed ID: 28652732
[TBL] [Abstract][Full Text] [Related]
3. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F
Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279
[TBL] [Abstract][Full Text] [Related]
5. A brain-vectored angiopep-2 based polymeric micelles for the treatment of intracranial fungal infection.
Shao K; Wu J; Chen Z; Huang S; Li J; Ye L; Lou J; Zhu L; Jiang C
Biomaterials; 2012 Oct; 33(28):6898-907. PubMed ID: 22789719
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.
Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR
Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of amphotericin B nanoparticles: antifungal activity, bioavailability and toxicity in rats.
Radwan MA; AlQuadeib BT; Šiller L; Wright MC; Horrocks B
Drug Deliv; 2017 Nov; 24(1):40-50. PubMed ID: 28155565
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice.
Xu N; Gu J; Zhu Y; Wen H; Ren Q; Chen J
Int J Nanomedicine; 2011; 6():905-13. PubMed ID: 21720503
[TBL] [Abstract][Full Text] [Related]
9. In vitro dissociation of antifungal efficacy and toxicity for amphotericin B-loaded poly(ethylene oxide)-block-poly(beta benzyl L aspartate) micelles.
Yu BG; Okano T; Kataoka K; Sardari S; Kwon GS
J Control Release; 1998 Dec; 56(1-3):285-91. PubMed ID: 9801451
[TBL] [Abstract][Full Text] [Related]
10. Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles.
Ren T; Xu N; Cao C; Yuan W; Yu X; Chen J; Ren J
J Biomater Sci Polym Ed; 2009; 20(10):1369-80. PubMed ID: 19622277
[TBL] [Abstract][Full Text] [Related]
11. A novel performing PEG-cholane nanoformulation for Amphotericin B delivery.
Luengo-Alonso C; Torrado JJ; Ballesteros MP; Malfanti A; Bersani S; Salmaso S; Caliceti P
Int J Pharm; 2015 Nov; 495(1):41-51. PubMed ID: 26319629
[TBL] [Abstract][Full Text] [Related]
12. Sustained intrathecal delivery of amphotericin B using an injectable and biodegradable thermogel.
Lin W; Xu T; Wang Z; Chen J
Drug Deliv; 2021 Dec; 28(1):499-509. PubMed ID: 33657949
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis.
Roy G; Galigama RD; Thorat VS; Mallela LS; Roy S; Garg P; Venuganti VVK
Int J Pharm; 2019 Dec; 572():118808. PubMed ID: 31678387
[TBL] [Abstract][Full Text] [Related]
14. Antifungal activity of oral (Tragacanth/acrylic acid) Amphotericin B carrier for systemic candidiasis: in vitro and in vivo study.
Mohamed HA; Radwan RR; Raafat AI; Ali AE
Drug Deliv Transl Res; 2018 Feb; 8(1):191-203. PubMed ID: 29280061
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B/sterol co-loaded PEG-phospholipid micelles: effects of sterols on aggregation state and hemolytic activity of amphotericin B.
Diezi TA; Kwon G
Pharm Res; 2012 Jul; 29(7):1737-44. PubMed ID: 22130733
[TBL] [Abstract][Full Text] [Related]
16. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
[TBL] [Abstract][Full Text] [Related]
17. PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting.
Monsalve Y; Tosi G; Ruozi B; Belletti D; Vilella A; Zoli M; Vandelli MA; Forni F; López BL; Sierra L
Nanomedicine (Lond); 2015; 10(11):1735-50. PubMed ID: 26080696
[TBL] [Abstract][Full Text] [Related]
18. Chitosan functionalized poly (ε-caprolactone) nanoparticles for amphotericin B delivery.
Vásquez Marcano RGDJ; Tominaga TT; Khalil NM; Pedroso LS; Mainardes RM
Carbohydr Polym; 2018 Dec; 202():345-354. PubMed ID: 30287009
[TBL] [Abstract][Full Text] [Related]
19. Low intensity ultrasound-mediated drug-loaded nanoparticles intravaginal drug delivery: an effective synergistic therapy scheme for treatment of vulvovaginal candidiasis.
Yang M; Cao Y; Zhang Z; Guo J; Hu C; Wang Z; Du Y
J Nanobiotechnology; 2023 Feb; 21(1):53. PubMed ID: 36782198
[TBL] [Abstract][Full Text] [Related]
20. Linolenic acid-modified MPEG-PEI micelles for encapsulation of amphotericin B.
Xu H; Teng F; Zhou F; Zhu L; Wen Y; Feng R; Song Z
Future Med Chem; 2019 Oct; 11(20):2647-2662. PubMed ID: 31621420
[No Abstract] [Full Text] [Related]
[Next] [New Search]
